Anatomically Selective Serotonergic Type 1A and Serotonergic Type 2A Therapies for Parkinson’s Disease: An Approach to Reducing Dyskinesia without Exacerbating Parkinsonism?

Newsletter

Get the latest science from Atuka

Sign up to receive our quarterly newsletter featuring the latest developments in Parkinson’s disease research.

List Signup

Talk to our experts

Advance your therapeutic program